LAURA SILLS: Open Payments
NPI 1699804104 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,540 in 183 payments from 22 companies in 2025. Trend: 2023 $3,752 · 2024 $4,589 · 2025 $3,540
Food & beverage: $3,540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $608 |
| Novartis Pharmaceuticals Corporation | 13 | $414 |
| Arcutis Biotherapeutics, Inc. | 21 | $387 |
| LEO Pharma Inc. | 9 | $332 |
| Amgen Inc. | 22 | $296 |
| Galderma Laboratories, L.P. | 12 | $256 |
| PFIZER INC. | 13 | $196 |
| Organogenesis Inc. | 4 | $174 |
| E.R. Squibb & Sons, L.L.C. | 6 | $160 |
| UCB, Inc. | 5 | $133 |
Products named: Zoryve, RINVOQ, OTEZLA, ADBRY, COSENTYX, NEMLUVIO, SKYRIZI, CIBINQO.
Industry payments across MO — which companies pay providers there.
